PET Scanners Market Size & Growth Forecast 2027–2036, By Segments (Modality, Application, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

PET Scanners Market size was valued at USD 2.9 billion in 2026 and is anticipated to grow at a 3.52% CAGR from 2027 to 2036, surpassing USD 4.1 billion by 2036. The industry revenue for 2027 is estimated at USD 2.99 billion.

• Base Year Value (2026): USD 2.9 billion
• CAGR (2027-2036): 3.52%
• Forecast Year Value (2036): USD 4.1 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

PET Scanners Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America captured 36.16% of the market in 2026, supported by advanced imaging infrastructure, strong PET utilization, mature procurement channels, and steady equipment replacement demand.
  • Asia Pacific is expected to grow at a 4.33% CAGR, driven by expanding healthcare infrastructure, greater investment in diagnostic imaging, and broader adoption of PET scanners across clinical settings.

• Segment Momentum:

  • PET-CT accounted for 77.81% of the market in 2026 by combining metabolic and anatomical imaging within one workflow, supporting confident diagnosis, treatment planning, and routine clinical use.
  • Cardiology is growing the fastest as providers increasingly require precise non-invasive cardiac imaging for myocardial assessment and treatment planning in complex cardiovascular cases.

• Market Expansion Drivers:

  • Rising cancer prevalence driving demand for advanced diagnostic imaging.
  • Technological advancements in PET-CT improving diagnostic accuracy and efficiency.
  • Increasing adoption of radiopharmaceuticals and targeted tracers in molecular imaging.

• Leading Market Participants:

  Top players in the PET scanners market include Siemens Healthineers AG (Germany), GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Shimadzu Corporation (Japan), Mediso Ltd. (Hungary), Positron Corporation (United States), PerkinElmer, Inc. (United States), United Imaging Healthcare Co., Ltd. (China), Bruker Corporation (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 2.9 billion
  • 2027 Estimated Market Size: USD 2.99 billion.
  • Projected Market Size: USD 4.1 billion by 2036
  • Growth Forecasts: 3.52% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: PET-CT (Modality) | Oncology (Application) | Hospitals (End Use)
  • Emerging Opportunity Segment: PET-CT (Modality) | Cardiology (Application) | Diagnostic Imaging Centers (End Use)

Market Growth Drivers and Industry Trends

Rising cancer prevalence driving demand for advanced diagnostic imaging

The PET scanners market is gaining momentum as rising cancer prevalence increases the need for advanced diagnostic imaging capable of supporting disease detection and evaluation. PET imaging provides clinicians with molecular and functional information that complements conventional diagnostic approaches, encouraging healthcare facilities to strengthen imaging capabilities for oncology-related assessment and patient management.

Technological advancements in PET-CT improving diagnostic accuracy and efficiency

Advances in PET-CT technology are improving the integration of metabolic and anatomical imaging, strengthening diagnostic workflows. For the PET scanners market, enhanced imaging capabilities can support more precise interpretation while improving operational efficiency, making technologically advanced systems increasingly relevant to healthcare providers seeking improved diagnostic performance.

Increasing adoption of radiopharmaceuticals and targeted tracers in molecular imaging

Growing use of radiopharmaceuticals and targeted tracers is broadening the clinical utility of molecular imaging. This trend supports the PET scanners market by increasing demand for imaging systems capable of working with tracer-based diagnostic approaches, particularly where clinicians require functional information to assess biological processes and disease characteristics.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising cancer prevalence driving demand for advanced diagnostic imaging	2.00%	High	North America, Europe	High	Near Term
Technological advancements in PET-CT improving diagnostic accuracy and efficiency	1.80%	High	Global	High	Mid Term
Increasing adoption of radiopharmaceuticals and targeted tracers in molecular imaging	1.70%	High	North America, Asia Pacific	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the largest share of the PET scanners market at 36.16% in 2026, underpinned by advanced diagnostic infrastructure, strong adoption of nuclear medicine technologies, and substantial demand for sophisticated imaging in oncology, cardiology, and neurological care. The region benefits from well-established healthcare systems and continued investment in upgrading imaging capabilities, while growing emphasis on early and precise disease detection is supporting the integration of PET imaging into clinical workflows. Demand is further reinforced by the increasing use of hybrid imaging technologies and the need for more effective monitoring of treatment response, particularly in complex and chronic diseases.

Asia Pacific is emerging as the fastest-growing region, driven by expanding healthcare infrastructure, improving access to advanced diagnostic services, and increasing investment in medical imaging capabilities. Rising healthcare expenditure and greater awareness of early disease diagnosis are encouraging hospitals and diagnostic centers to adopt advanced PET-based technologies. The expansion of specialized cancer-care facilities and improvements in healthcare delivery across developing markets are also broadening the addressable patient base. In addition, technological advancements that improve imaging efficiency and diagnostic precision are supporting wider adoption, positioning Asia Pacific as a key growth market for PET scanners.

Key Country Insights

United States

Clinical Innovation Hub

The U.S. continues to prioritize advanced PET scanner adoption across oncology, neurology, and cardiology, supported by integrated healthcare networks and ongoing imaging technology upgrades. Demand increasingly favors systems that improve diagnostic precision, workflow efficiency, and compatibility with hybrid imaging platforms.

Japan

Aging Care Imaging

Japan expands PET scanner utilization to address growing diagnostic requirements associated with an aging population. Healthcare providers prioritize compact, reliable systems with enhanced image quality and efficient patient throughput for routine clinical practice.

South Korea

Digital Imaging Integration

South Korea strengthens PET scanner deployment through digitally connected hospitals and advanced diagnostic infrastructure. Market activity centers on AI-enabled image processing, streamlined clinical workflows, and compatibility with precision medicine initiatives.

Germany

Precision Imaging Focus

Germany emphasizes high-performance PET scanners for specialized diagnostic centers and university hospitals. The country supports investments in imaging systems that enhance quantitative analysis, operational efficiency, and integration with advanced radiology and nuclear medicine workflows.

France

Hospital Modernization Drive

France continues upgrading PET scanner capabilities within public and regional healthcare facilities to improve diagnostic access. Procurement decisions increasingly favor systems offering operational efficiency, lower maintenance requirements, and advanced imaging performance.

Italy

Regional Diagnostic Expansion

Italy focuses on expanding PET scanner availability across regional healthcare networks while modernizing existing imaging infrastructure. Buyers seek versatile systems that improve diagnostic consistency and support multidisciplinary clinical applications.

Segment Leadership and Growth Trends

 

Modality Segment Analysis: PET-CT (Largest & Fastest-Growing Segment)

PET-CT held the largest share of the PET scanners market in 2026, accounting for 77.81%, while also representing the fastest-growing modality. Its strong position is driven by the ability to combine functional information from positron emission tomography with detailed anatomical imaging from computed tomography, enabling more comprehensive disease assessment. PET-CT is particularly valuable where clinicians need to identify abnormal metabolic activity while accurately localizing lesions, supporting diagnosis, staging, treatment planning, and follow-up. Increasing demand for integrated diagnostic imaging and greater emphasis on precise clinical decision-making continue to strengthen adoption of this modality.

Application Segment Analysis: Oncology (Largest Segment) vs Cardiology (Fastest-Growing Segment)

Oncology dominated the PET scanners market in 2026, accounting for 49.82% of the market, reflecting the extensive role of PET imaging in cancer detection, staging, treatment planning, and response assessment. PET-based metabolic imaging provides clinicians with information that complements anatomical scans, helping identify active disease and evaluate changes during treatment. Growing emphasis on earlier and more precise cancer assessment, together with the increasing use of hybrid imaging, continues to support oncology as the leading application area.

Cardiology is emerging as the fastest-growing application segment as PET imaging gains greater relevance in the assessment of myocardial perfusion, viability, and cardiovascular disease. The ability to obtain functional information can assist clinicians in evaluating cardiac tissue and supporting treatment decisions, particularly when conventional anatomical assessment may provide limited insight. Increasing attention to early cardiovascular diagnosis and more personalized disease management is encouraging broader use of advanced metabolic imaging in cardiac care.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Modality	PET-CT, PET-MRI	PET-CT	PET-CT
Application	Oncology, Cardiology, Neurology	Oncology	Cardiology
End Use	Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes	Hospitals	Diagnostic Imaging Centers

Competitive Landscape and Market Positioning

Major players in the PET scanners market:

1. Siemens Healthineers AG (Germany)

2. GE HealthCare Technologies Inc. (United States)

3. Koninklijke Philips N.V. (Netherlands)

4. Canon Medical Systems Corporation (Japan)

5. Shimadzu Corporation (Japan)

6. Mediso Ltd. (Hungary)

7. Positron Corporation (United States)

8. PerkinElmer Inc. (United States)

9. United Imaging Healthcare Co. Ltd. (China)

10. Bruker Corporation (United States)

Diagnostic imaging advancements are accelerating evolution in the PET scanners market. Improved resolution and faster imaging processes are enhancing clinical decision-making. The PET scanners market is also experiencing growing demand due to rising adoption of precision diagnostics.

Industry Development/News

Company Name	Date	Key Development
Sutter Health	Oct-25	Sutter Health entered a seven-year, $1 billion agreement with GE HealthCare to modernize diagnostic imaging infrastructure across Northern California. This strategic partnership focuses on the large-scale deployment of AI-enabled technologies, facilitating the expansion of advanced imaging systems and enhancing operational workflow capabilities within the regional healthcare network.
Telix Pharmaceuticals	Oct-25	Telix Pharmaceuticals commenced U.S. commercialization of Gozellix, its PET imaging agent for prostate cancer. By establishing distribution channels for this diagnostic agent, the company expands clinical access to targeted nuclear medicine applications, strengthening its competitive positioning in the specialized oncological imaging market.
Neurophet	Oct-25	Neurophet signed an exclusive sales agreement with Lado Technology and initiated plans for a joint venture to facilitate entry into the Chinese market. This expansion strategy aims to scale the commercial reach of its AI-driven brain imaging solutions, integrating advanced neuro-imaging software into regional nuclear medicine workflows.
CDL Nuclear Technologies	Apr-24	CDL Nuclear Technologies introduced a mobile cardiac PET/CT trailer, providing healthcare facilities with flexible access to specialized nuclear imaging services. This on-demand model addresses capital barriers to entry for advanced cardiac diagnostics, enabling medical centers to deploy high-resolution PET/CT capabilities without permanent on-site infrastructure investments.
Siemens Healthineers	Oct-25	Siemens Healthineers initiated a field corrective action for specific PET imaging systems following reports of potential image artifacts. This quality management intervention ensures the maintenance of clinical diagnostic standards and system reliability for the installed base of PET scanners, reflecting ongoing efforts to manage performance consistency in medical imaging operations.
Industry Development	Jun-24	The clinical emergence of Augmented Whole-Body Scanning via Magnifying PET (AWSM-PET) represents a material technical advancement in PET/CT imaging. This innovation provides measurable improvements in system sensitivity and image clarity, enabling higher resolution whole-body diagnostic outcomes compared to traditional scanning methodologies, with potential for broader adoption in clinical oncological screening.